These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 16006591

  • 1. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.
    Robben JH, Knoers NV, Deen PM.
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F265-72. PubMed ID: 16006591
    [Abstract] [Full Text] [Related]

  • 2. Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus.
    Robben JH, Sze M, Knoers NV, Deen PM.
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F253-60. PubMed ID: 16926443
    [Abstract] [Full Text] [Related]

  • 3. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
    Oksche A, Schülein R, Rutz C, Liebenhoff U, Dickson J, Müller H, Birnbaumer M, Rosenthal W.
    Mol Pharmacol; 1996 Oct; 50(4):820-8. PubMed ID: 8863826
    [Abstract] [Full Text] [Related]

  • 4. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
    Cheong HI, Cho HY, Park HW, Ha IS, Choi Y.
    Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
    [Abstract] [Full Text] [Related]

  • 5. Derlin-1 and p97/valosin-containing protein mediate the endoplasmic reticulum-associated degradation of human V2 vasopressin receptors.
    Schwieger I, Lautz K, Krause E, Rosenthal W, Wiesner B, Hermosilla R.
    Mol Pharmacol; 2008 Mar; 73(3):697-708. PubMed ID: 18048502
    [Abstract] [Full Text] [Related]

  • 6. Potential of nonpeptide (ant)agonists to rescue vasopressin V2 receptor mutants for the treatment of X-linked nephrogenic diabetes insipidus.
    Los EL, Deen PM, Robben JH.
    J Neuroendocrinol; 2010 May; 22(5):393-9. PubMed ID: 20163515
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Appropriate polarization following pharmacological rescue of V2 vasopressin receptors encoded by X-linked nephrogenic diabetes insipidus alleles involves a conformation of the receptor that also attains mature glycosylation.
    Tan CM, Nickols HH, Limbird LE.
    J Biol Chem; 2003 Sep 12; 278(37):35678-86. PubMed ID: 12824183
    [Abstract] [Full Text] [Related]

  • 15. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
    Robben JH, Knoers NV, Deen PM.
    Am J Physiol Renal Physiol; 2006 Aug 12; 291(2):F257-70. PubMed ID: 16825342
    [Abstract] [Full Text] [Related]

  • 16. Relief of nocturnal enuresis by desmopressin is kidney and vasopressin type 2 receptor independent.
    Robben JH, Sze M, Knoers NV, Eggert P, Deen P, Müller D.
    J Am Soc Nephrol; 2007 May 12; 18(5):1534-9. PubMed ID: 17389737
    [Abstract] [Full Text] [Related]

  • 17. Functional characterization of novel loss-of-function mutations in the vasopressin type 2 receptor gene causing nephrogenic diabetes insipidus.
    Böselt I, Tramma D, Kalamitsou S, Niemeyer T, Nykänen P, Gräf KJ, Krude H, Marenzi KS, Di Candia S, Schöneberg T, Schulz A.
    Nephrol Dial Transplant; 2012 Apr 12; 27(4):1521-8. PubMed ID: 21917732
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant.
    Rosenthal W, Seibold A, Antaramian A, Gilbert S, Birnbaumer M, Bichet DG, Arthus MF, Lonergan M.
    Cell Mol Biol (Noisy-le-grand); 1994 May 12; 40(3):429-36. PubMed ID: 7920187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.